Pascual E
A platform that enables continuous monitoring and brings together multiple health parameters can help bridge this gap, offering better visibility into outcomes and enabling more proactive patient management. One of the biggest challenges with GLP therapies today is the lack of continuous visibility into how patients are responding outside the clinic
The Silent Threat: Chronic Inflammation and Metabolic Health Obesity and metabolic dysfunction are increasingly understood as states driven by chronic low-grade inflammation
AMS Edmonton, Alberta Hogan AE, Tobin AM, Ahern T, Corrigan MA, Gaoatswe G, Jackson R, OReilly V, Lynch L, Doherty DG, Moynagh PN, Kirby B, OConnell J, & OShea D (2011)
How Should I Store my BPC-157 Capsules?
Clinical studies examining this specific combination remain limited, so current evidence relies on mechanism-based reasoning and observational clinical reports rather than large randomized trials